Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 119
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05733793 | Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients. | ||
| NCT04123925 | Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study | ||
| NCT07459920 | Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden | ||
| NCT07290894 | Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01 | ||
| NCT03503786 | Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer | ||
| NCT07213570 | STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer | ||
| NCT01061619 | Pathway to Diagnosis of Ovarian Cancer | ||
| NCT06894823 | Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT) | ||
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | ||
| NCT05806151 | Prediction of True Oligo-metastatic Disease. | ||
| NCT04595032 | MAnagement of METastatic Disease in Campania (MAMETIC) | ||
| NCT04071704 | Assessing Health-related Quality of Life in Sarcoma Patients | ||
| NCT05233982 | MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer | ||
| NCT00996983 | Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer | ||
| NCT06236464 | Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas | ||
| NCT01898104 | Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer | ||
| NCT01755182 | Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors | ||
| NCT06905262 | Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt) | ||
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | ||
| NCT07354165 | Financial Toxicity in Patients With Early-stage Breast Cancer | ||
| NCT00997009 | Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer | ||
| NCT04425239 | Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer | ||
| NCT05818020 | Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies | ||
| NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | ||
| NCT03473379 | Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy | ||
| NCT04893785 | A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) | ||
| NCT07522697 | Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4 | ||
| NCT02786875 | Diet, Exercise and Vitamin D in Breast Cancer Recurrence | ||
| NCT00660842 | Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer | ||
| NCT01405586 | MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer | ||
| NCT02618850 | PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment | ||
| NCT07213557 | Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy | ||
| NCT02624128 | Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck | ||
| NCT05733806 | Study on Gynecological Rare Cancers | ||
| NCT04397601 | Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer | ||
| NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | ||
| NCT00415779 | ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer | ||
| NCT06880523 | STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma | ||
| NCT07175350 | Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study | ||
| NCT06341764 | Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma | ||
| NCT04317092 | Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) | ||
| NCT03874026 | Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients | ||
| NCT00326456 | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer | ||
| NCT05821556 | Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients | ||
| NCT04091204 | Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study | ||
| NCT03410784 | Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer | ||
| NCT02381054 | Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients | ||
| NCT01644825 | Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer | ||
| NCT01651013 | Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras | ||
| NCT02273375 | Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC |
